MLPA identification of dystrophin mutations and in silico evaluation of the predicted protein in dystrophinopathy cases from India

Abstract Background Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are X-linked recessive disorders caused by mutations in the DMD gene. The aim of this study was to predict the effect of gene mutations on the dystrophin protein and study its impact on clinical phenotype. Meth...

Full description

Bibliographic Details
Main Authors: Sekar Deepha, Seena Vengalil, Veeramani Preethish-Kumar, Kiran Polavarapu, Atchayaram Nalini, Narayanappa Gayathri, Meera Purushottam
Format: Article
Language:English
Published: BMC 2017-06-01
Series:BMC Medical Genetics
Subjects:
DMD
Online Access:http://link.springer.com/article/10.1186/s12881-017-0431-6
id doaj-f88971830725440482236abe718df002
record_format Article
spelling doaj-f88971830725440482236abe718df0022021-04-02T13:38:14ZengBMCBMC Medical Genetics1471-23502017-06-0118111010.1186/s12881-017-0431-6MLPA identification of dystrophin mutations and in silico evaluation of the predicted protein in dystrophinopathy cases from IndiaSekar Deepha0Seena Vengalil1Veeramani Preethish-Kumar2Kiran Polavarapu3Atchayaram Nalini4Narayanappa Gayathri5Meera Purushottam6Department of Neuropathology, Neuromuscular LaboratoryDepartment of Neurology, National Institute of Mental Health and NeurosciencesDepartment of Neurology, National Institute of Mental Health and NeurosciencesDepartment of Neurology, National Institute of Mental Health and NeurosciencesDepartment of Neurology, National Institute of Mental Health and NeurosciencesDepartment of Neuropathology, Neuromuscular LaboratoryMolecular Genetics Laboratory, Neurobiology Research Centre, Department of Psychiatry, National Institute of Mental Health and NeurosciencesAbstract Background Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are X-linked recessive disorders caused by mutations in the DMD gene. The aim of this study was to predict the effect of gene mutations on the dystrophin protein and study its impact on clinical phenotype. Methods In this study, 415 clinically diagnosed patients were tested for mutations by Multiplex ligation dependent probe amplification (MLPA). Muscle biopsy was performed in 34 patients with negative MLPA. Phenotype-genotype correlation was done using PROVEAN, hydrophobicity and eDystrophin analysis. We have utilized bioinformatics tools in order to evaluate the observed mutations both at the level of primary as well as secondary structure. Results Mutations were identified in 75.42% cases, of which there were deletions in 91.6% and duplications in 8.30%. As per the reading frame rule, 84.6% out-of frame and 15.3% in-frame mutations were noted. Exon 50 was the most frequently deleted exon and the exon 45–52 region was the hot-spot for deletions in this cohort. There was no correlation noted between age of onset or creatine kinase (CK) values with extent of gene mutation. The PROVEAN analysis showed a deleterious effect in 94.5% cases and a neutral effect in 5.09% cases. Mutations in exon 45–54 (out of frame) and exon 46–54 (in-frame) regions in the central rod domain of dystrophin showed more negative scores compared to other domains in the present study. Hydrophobicity profile analysis showed that the hydrophobic regions I & III were equally affected. Analysis of deletions in hinge III hydrophobic region by the eDystrophin programme also predicted a hybrid repeat seen to be associated with a BMD like disease progression, thus making the hinge III region relatively tolerant to mutations. Conclusions We found that, while the predictions made by the software utilized might have overall significance, the results were not convincing on a case by case basis. This reflects the inadequacy of the currently available tools and also underlines the possible inadequacy of MLPA to detect other minor mutations that might enhance or suppress the effect of the primary mutation in this large gene. Next Generation Sequencing or targeted Sanger sequencing on a case by case basis might improve phenotype- genotype correlation.http://link.springer.com/article/10.1186/s12881-017-0431-6DMDMLPAPROVEANHydrophobicity profileeDystrophin
collection DOAJ
language English
format Article
sources DOAJ
author Sekar Deepha
Seena Vengalil
Veeramani Preethish-Kumar
Kiran Polavarapu
Atchayaram Nalini
Narayanappa Gayathri
Meera Purushottam
spellingShingle Sekar Deepha
Seena Vengalil
Veeramani Preethish-Kumar
Kiran Polavarapu
Atchayaram Nalini
Narayanappa Gayathri
Meera Purushottam
MLPA identification of dystrophin mutations and in silico evaluation of the predicted protein in dystrophinopathy cases from India
BMC Medical Genetics
DMD
MLPA
PROVEAN
Hydrophobicity profile
eDystrophin
author_facet Sekar Deepha
Seena Vengalil
Veeramani Preethish-Kumar
Kiran Polavarapu
Atchayaram Nalini
Narayanappa Gayathri
Meera Purushottam
author_sort Sekar Deepha
title MLPA identification of dystrophin mutations and in silico evaluation of the predicted protein in dystrophinopathy cases from India
title_short MLPA identification of dystrophin mutations and in silico evaluation of the predicted protein in dystrophinopathy cases from India
title_full MLPA identification of dystrophin mutations and in silico evaluation of the predicted protein in dystrophinopathy cases from India
title_fullStr MLPA identification of dystrophin mutations and in silico evaluation of the predicted protein in dystrophinopathy cases from India
title_full_unstemmed MLPA identification of dystrophin mutations and in silico evaluation of the predicted protein in dystrophinopathy cases from India
title_sort mlpa identification of dystrophin mutations and in silico evaluation of the predicted protein in dystrophinopathy cases from india
publisher BMC
series BMC Medical Genetics
issn 1471-2350
publishDate 2017-06-01
description Abstract Background Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are X-linked recessive disorders caused by mutations in the DMD gene. The aim of this study was to predict the effect of gene mutations on the dystrophin protein and study its impact on clinical phenotype. Methods In this study, 415 clinically diagnosed patients were tested for mutations by Multiplex ligation dependent probe amplification (MLPA). Muscle biopsy was performed in 34 patients with negative MLPA. Phenotype-genotype correlation was done using PROVEAN, hydrophobicity and eDystrophin analysis. We have utilized bioinformatics tools in order to evaluate the observed mutations both at the level of primary as well as secondary structure. Results Mutations were identified in 75.42% cases, of which there were deletions in 91.6% and duplications in 8.30%. As per the reading frame rule, 84.6% out-of frame and 15.3% in-frame mutations were noted. Exon 50 was the most frequently deleted exon and the exon 45–52 region was the hot-spot for deletions in this cohort. There was no correlation noted between age of onset or creatine kinase (CK) values with extent of gene mutation. The PROVEAN analysis showed a deleterious effect in 94.5% cases and a neutral effect in 5.09% cases. Mutations in exon 45–54 (out of frame) and exon 46–54 (in-frame) regions in the central rod domain of dystrophin showed more negative scores compared to other domains in the present study. Hydrophobicity profile analysis showed that the hydrophobic regions I & III were equally affected. Analysis of deletions in hinge III hydrophobic region by the eDystrophin programme also predicted a hybrid repeat seen to be associated with a BMD like disease progression, thus making the hinge III region relatively tolerant to mutations. Conclusions We found that, while the predictions made by the software utilized might have overall significance, the results were not convincing on a case by case basis. This reflects the inadequacy of the currently available tools and also underlines the possible inadequacy of MLPA to detect other minor mutations that might enhance or suppress the effect of the primary mutation in this large gene. Next Generation Sequencing or targeted Sanger sequencing on a case by case basis might improve phenotype- genotype correlation.
topic DMD
MLPA
PROVEAN
Hydrophobicity profile
eDystrophin
url http://link.springer.com/article/10.1186/s12881-017-0431-6
work_keys_str_mv AT sekardeepha mlpaidentificationofdystrophinmutationsandinsilicoevaluationofthepredictedproteinindystrophinopathycasesfromindia
AT seenavengalil mlpaidentificationofdystrophinmutationsandinsilicoevaluationofthepredictedproteinindystrophinopathycasesfromindia
AT veeramanipreethishkumar mlpaidentificationofdystrophinmutationsandinsilicoevaluationofthepredictedproteinindystrophinopathycasesfromindia
AT kiranpolavarapu mlpaidentificationofdystrophinmutationsandinsilicoevaluationofthepredictedproteinindystrophinopathycasesfromindia
AT atchayaramnalini mlpaidentificationofdystrophinmutationsandinsilicoevaluationofthepredictedproteinindystrophinopathycasesfromindia
AT narayanappagayathri mlpaidentificationofdystrophinmutationsandinsilicoevaluationofthepredictedproteinindystrophinopathycasesfromindia
AT meerapurushottam mlpaidentificationofdystrophinmutationsandinsilicoevaluationofthepredictedproteinindystrophinopathycasesfromindia
_version_ 1721564323609837568